Table 2.
Patient Characteristics in Elective and Urgent Groups at Initial Presentation for Embolization
| Characteristic | Elective | Urgent | P Value |
|---|---|---|---|
| Sex | .74 | ||
| Male | 50 (47) | 13 (43) | |
| Female | 57 (53) | 17 (57) | |
| Age (y) | 58 ± 12 | 56 ± 12 | .34 |
| Pathology | .39 | ||
| Carcinoid | 63 (59) | 15 (50) | |
| Pancreatic NET | 44 (41) | 15 (50) | |
| Liver involvement with metastatic disease | .16 | ||
| ≤ 50% | 63 (59) | 12 (40) | |
| > 50% | 43 (40) | 15 (50) | |
| Unknown | 1 (1) | 3 (10) | |
| Extrahepatic metastasis | .84 | ||
| Yes | 45 (42) | 12 (40) | |
| No | 62 (58) | 18 (60) | |
| Indication for embolization | .23 | ||
| Primary treatment | 31 (29) | 11 (37) | |
| Recurrence after surgery | 21 (20) | 2 (6) | |
| Progression despite medical treatment | 55 (51) | 17 (57) | |
| Mean (95% CI) diagnosis–HAE interval (mo) | 28 (20–36) | 21 (21) | .32 |
Values in parentheses are percentages. Values presented as mean ± standard deviation where applicable.
CI = confidence interval, HAE = hepatic artery embolization, NET = neuroendocrine tumor.